These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33258470)

  • 21. A glycolysis-related two-gene risk model that can effectively predict the prognosis of patients with rectal cancer.
    Liu Z; Liu Z; Zhou X; Lu Y; Yao Y; Wang W; Lu S; Wang B; Li F; Fu W
    Hum Genomics; 2022 Feb; 16(1):5. PubMed ID: 35109912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detecting Prognosis Risk Biomarkers for Colon Cancer Through Multi-Omics-Based Prognostic Analysis and Target Regulation Simulation Modeling.
    Yin Z; Yan X; Wang Q; Deng Z; Tang K; Cao Z; Qiu T
    Front Genet; 2020; 11():524. PubMed ID: 32528533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Correlation of Wnt2 and COL8A1 With Colon Adenocarcinoma Prognosis.
    Zhang L; Jiang X; Li Y; Fan Q; Li H; Jin L; Li L; Jin Y; Zhang T; Mao Y; Hua D
    Front Oncol; 2020; 10():1504. PubMed ID: 32983993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma.
    Miao YD; Kou ZY; Wang JT; Mi DH
    World J Clin Cases; 2021 Oct; 9(29):8671-8693. PubMed ID: 34734046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive analysis of microRNA/mRNA signature in colon adenocarcinoma.
    Wang JY; Wang CL; Wang XM; Liu FJ
    Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2114-2129. PubMed ID: 28537673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multi-Omics Characterization of a Glycerolipid Metabolism-Related Gene Enrichment Score in Colon Cancer.
    Wang Z; Zhang Z; Zhang K; Zhou Q; Chen S; Zheng H; Wang G; Cai S; Wang F; Li S
    Front Oncol; 2022; 12():881953. PubMed ID: 35600382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In silico development and clinical validation of novel 8 gene signature based on lipid metabolism related genes in colon adenocarcinoma.
    Jiang C; Liu Y; Wen S; Xu C; Gu L
    Pharmacol Res; 2021 Jul; 169():105644. PubMed ID: 33940186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucose metabolism-based signature predicts prognosis and immunotherapy strategies for colon adenocarcinoma.
    Bai Z; Yan C; Nie Y; Zeng Q; Xu L; Wang S; Chang D
    J Gene Med; 2024 Jan; 26(1):e3620. PubMed ID: 37973153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Capturing the latent space of an Autoencoder for multi-omics integration and cancer subtyping.
    Madhumita ; Paul S
    Comput Biol Med; 2022 Sep; 148():105832. PubMed ID: 35834966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deep Learning-Based Multi-Omics Data Integration Reveals Two Prognostic Subtypes in High-Risk Neuroblastoma.
    Zhang L; Lv C; Jin Y; Cheng G; Fu Y; Yuan D; Tao Y; Guo Y; Ni X; Shi T
    Front Genet; 2018; 9():477. PubMed ID: 30405689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deep learning based feature-level integration of multi-omics data for breast cancer patients survival analysis.
    Tong L; Mitchel J; Chatlin K; Wang MD
    BMC Med Inform Decis Mak; 2020 Sep; 20(1):225. PubMed ID: 32933515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
    Jin L; Li C; Liu T; Wang L
    Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of necroptosis-related genes for predicting prognosis and exploring immune infiltration landscape in colon adenocarcinoma.
    Wang Y; Lin MG; Meng L; Chen ZM; Wei ZJ; Ying SC; Xu A
    Front Oncol; 2022; 12():941156. PubMed ID: 36505813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a prognostic model for personalized prediction of colon adenocarcinoma (COAD) patient outcomes using methylation-driven genes.
    Chen D; Zhang B; Kang K; Li L; Liao Y; Qing S; Di Y
    J Appl Genet; 2023 Dec; 64(4):713-721. PubMed ID: 37589877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction and validation of a prognostic model for colon adenocarcinoma based on bile acid metabolism-related genes.
    Luo Q; Zhou P; Chang S; Huang Z; Zeng X
    Sci Rep; 2023 Aug; 13(1):12728. PubMed ID: 37543674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma.
    He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q
    Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MMDAE-HGSOC: A novel method for high-grade serous ovarian cancer molecular subtypes classification based on multi-modal deep autoencoder.
    Wang HQ; Li HL; Han JL; Feng ZP; Deng HX; Han X
    Comput Biol Chem; 2023 Aug; 105():107906. PubMed ID: 37336028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel enterocyte-related 4-gene signature for predicting prognosis in colon adenocarcinoma.
    Cheng X; Wei Y; Fu Y; Li J; Han L
    Front Immunol; 2022; 13():1052182. PubMed ID: 36532007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrating multi-omics data through deep learning for accurate cancer prognosis prediction.
    Chai H; Zhou X; Zhang Z; Rao J; Zhao H; Yang Y
    Comput Biol Med; 2021 Jul; 134():104481. PubMed ID: 33989895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.